Showing results (161-170 of 197) with videos related to
Sort By:
Pageof 20
The Journal of Experimental Medicine|March 12, 2014
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Peter G Miller, Lisa P Chu, et al.Gut Microbes|November 7, 2022
Formation of secondary allo-bile acids by novel enzymes from gut FirmicutesJae Won Lee, Elise S Cowley, Patricia G Wolf, et al.Cell|April 9, 2016
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AMLRishi V Puram, Monika S Kowalczyk, Carl G de Boer, et al.Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.Cell Reports|August 3, 2024
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiationYu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, et al.Cell|August 21, 2012
Cancer vulnerabilities unveiled by genomic lossDeepak Nijhawan, Travis I Zack, Yin Ren, et al.Nature|January 31, 2014
In vivo discovery of immunotherapy targets in the tumour microenvironmentPenghui Zhou, Donald R Shaffer, Diana A Alvarez Arias, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2017
<i>PIK3CA</i> mutant tumors depend on oxoglutarate dehydrogenaseNina Ilic, Kıvanç Birsoy, Andrew J Aguirre, et al.Cancer Cell|December 17, 2013
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancerLianjie Li, Chuan Shen, Eijiro Nakamura, et al.Science Translational Medicine|August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.Pageof 20